Avenue Therapeutics, Inc. (ATXI)
NASDAQ: ATXI · Real-Time Price · USD
2.060
+0.080 (4.04%)
Nov 21, 2024, 2:45 PM EST - Market open

Avenue Therapeutics Stock Forecast

ATXI's stock price has decreased by -86.9% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Avenue Therapeutics stock has a target of 56.25, which predicts an increase of 2,630.58% from the current stock price of 2.06.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $56.25 $56.25 $56.25 $56.25
Change +2630.6% +2630.6% +2630.6% +2630.6%
* Price targets were last updated on Dec 11, 2023.

Analyst Ratings

According to 1 stock analyst, the rating for ATXI is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Aug '23Sep '23Oct '23Nov '23Dec '23
Strong Buy 11111
Buy 00000
Hold 00000
Sell 00000
Strong Sell 00000
Total 11111

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Maxim Group
Maxim Group
Strong Buy
Initiates
$56
Strong Buy Initiates $56 +2,630.58% Dec 11, 2023
Aegis Capital
Aegis Capital
Strong Buy
Initiates
$2,400
Strong Buy Initiates $2,400 +116,404.85% Apr 3, 2023
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$13,500$14,625
Strong Buy Maintains $13,500$14,625 +709,851.46% May 12, 2020
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Initiates
$12,375
Strong Buy Initiates $12,375 +600,628.16% Jun 25, 2018
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-6.49
from -73.48
EPS Next Year
-3.20
from -6.49
Fiscal Year FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Dec 31, 2019 Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026
Revenue
--------
Revenue Growth
--------
EPS
-1,853.88-351.08-246.94-121.92-73.48-6.49-3.20-2.85
EPS Growth
--------
Forward PE
--------
No. Analysts -----333
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202420252026
High n/a n/a n/a
Avg n/a n/a n/a
Low n/a n/a n/a

Revenue Growth

Revenue Growth 202420252026
High - - -
Avg - - -
Low - - -

EPS Forecast

EPS 202420252026
High -6.68 -3.30 -2.93
Avg -6.49 -3.20 -2.85
Low -6.23 -3.08 -2.73

EPS Growth

EPS Growth 202420252026
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.